Genito Urinary System And Sex Hormones
Jnana reports topline data from Phase Ia trial of PKU therapy
Jnana Therapeutics has reported positive topline data from the Phase Ia clinical trial of JNT-517, a potential first-in-class oral treatment…
Pipeline Moves: Novo Nordisk Phase III semaglutide completion bumps approval prospects
This week on Pipeline Moves, we start the week by looking at the completion of the Phase III trial investigating…
Pipeline Moves: Hengrui Medicine Phase III breast cancer termination lowers approval prospects
This week on Pipeline Moves, we start by investigating terminations of a Phase III trial in breast cancer, a Phase…
Pipeline Moves: Pfizer terminates glomerulosclerosis trial, advancement prospects drop
This week on Pipeline Moves, we start off by looking at the terminations of a Phase II focal segmental glomerulosclerosis…
Travere’s Filspari reduces urine protein levels in adults with IgAN
San Diego-based Travere Therapeutics announced positive interim results from a Phase III trial investigating Filspari (sparsentan) in adults with IgA…
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Pipeline Moves: positive topline results for epilepsy drug, advancement prospects jump
This week on Pipeline Moves, we start off on a good note by looking at positive topline results from a…
Vera concludes Phase IIb IgA nephropathy trial subject enrolment
Vera Therapeutics has concluded subject enrolment in the Phase IIb ORIGIN clinical trial of atacicept in IgA nephropathy (IgAN) patients.…
Urovant reports positive data from Phase IIa OAB therapy trial
Urovant Sciences has reported positive topline data from the Phase IIa clinical trial of its investigational gene therapy product, URO-902,…
Major unmet needs in overactive bladder unlikely to be addressed in the near future
Unmet needs within the overactive bladder (OAB) market are significant and largely expected to persist throughout the next decade, according…
Regulatory roundup: Editas’ CRISPR asset make strides after positive eye disease trial
Need to know: GlobalData’s Investigative News team reviews data generated by an in-house model that combines machine learning and its…